Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
Expert Market

NPHCNutra Pharma Corp.

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About Nutra Pharma Corp. (NPHC)

Nutra Pharma Corp. (NPHC) is a Drug Manufacturers - Specialty & Generic company headquartered in Plantation, FL, United States whose shares trade over-the-counter on the Expert Market tier.

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brands Nyloxin, Pet Pain-Away, Equine Pain-Away and Luxury Feet..

Products and services

Nutra Pharma Corporation has ethical drugs in clinical development for the treatment of Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain. Our MS drug has received Orphan Designation from the FDA for the treatment of juvenile MS. Additionally, the Company markets drug products for sale for the treatment of pain under the brands Nyloxin®, Luxury Feet™, Equine Pain-Away™ and Pet Pain-Away™. The Company is also working on nerve agent countermeasures against organophosphate chemicals. Lastly, the company produces homeopathic drugs and dietary supplements for several private label customers, including Avini Health.

NPHC key facts

Ticker symbol
NPHC
Market tier
Expert Market
Headquarters
Plantation, FL, United States
Country of incorporation
US
Year of incorporation
2000
Employees
8
Estimated market cap
$2.13M (as of Apr 16, 2025)
Shares outstanding
7,099,739,773
Reporting standard
U.S. Reporting: SEC Reporting
Audit status
Audited
Fiscal year end
12/31

Nutra Pharma Corp. leadership

  • Michael Flax — CEO
  • Rik J Deitsch — Manager, Ops.

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with N

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for Nutra Pharma Corp. (NPHC) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Fax
Not provided
Investor Relations Email
Not provided
Headquarters Address
1537 NW 65th Avenue
Plantation, FL, 33313
United States

Company Leadership

Chief Executive Officer

C
CEO Information Not Available
Chief Executive Officer

Company Officers

Michael Flax
CEO
Rik J Deitsch
Manager, Ops.

Social Media

Business Details

Stock Details

Loading modules...